Relationship of Hospitalized COVID-19 Patients and Thyroid Dysfunction

Aims: Although vaccines have been developed for COVID-19, the virus continues to present problems to the health sector. The current study assessed thyroid function in all hospitalized patients diagnosed with the virus to ascertain whether COVID-19 infection was linked to thyroid function abnormalities. Instrument Methods: An observational cohort study was conducted on all COVID-19-positive patients hospitalized in the Al-Fourat Al-Awsat Hospital in Al-Kufa, Iraq, between September 2021 and April 2022. 208 potential patients were tested during this period, and 150 COVID-19 patients and 50 COVID-19-negative individuals were selected. A sample of blood was collected during hospitalization. A serum was used to determine the thyroid-stimulating hormone. Findings: Hypertension, shortness of breath, diabetes, liver dysfunction, and cardiac and pro-inflammatory diseases were the most frequent comorbidities in COVID-19 patients. The association between COVID-19 and Control groups indicated a significant difference in age, body mass index, gender, systolic- and diastolic blood pressure, fasting blood sugar, HbA1C, alanine aminotransferase, and aspartate aminotransferase. Also, the analysis indicated a significant (p 0.001) difference between COVID-19 patients and the control group in the level of TSH. Conclusion: Thyroid impairment is frequent in most individuals admitted to the hospital with a COVID-19 infection. Low thyroid-stimulating hormone level is a reliable indicator of poor prognosis in COVID-19-infected individuals.